Spots Global Cancer Trial Database for paricalcitol
Every month we try and update this database with for paricalcitol cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D | NCT00977080 | Chronic Kidney ... Secondary Hyper... Hemodialysis | Paricalcitol Cinacalcet | 18 Years - | Abbott | |
| Comparison of Efficacy and Safety of Paricalcitol Injection With Maxacalcitol Injection in Adult Japanese Chronic Kidney Disease Subjects Receiving Hemodialysis With Secondary Hyperparathyroidism | NCT01341782 | Secondary Hyper... Hemodialysis | paricalcitol maxacalcitol paricalcitol pl... maxacalcitol pl... | 20 Years - | AbbVie | |
| Paricalcitol Plus Gemcitabine and Nab-paclitaxel in Metastatic Pancreatic Cancer | NCT03520790 | Pancreatic Canc... | Gemcitabine Nab-paclitaxel Paricalcitol Placebo | 18 Years - | Dana-Farber Cancer Institute | |
| A Pilot Study of Perioperative Nivolumab and Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer | NCT03519308 | Pancreatic Canc... | Nivolumab Nab-Paclitaxel Gemcitabine Paricalcitol | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD) | NCT04064827 | Chronic Kidney ... Secondary Hyper... | Paricalcitol | 0 Years - 9 Years | AbbVie | |
| Extension Study of CTAP101-CL-3001 or CTAP101-CL-3002 | NCT02282813 | Chronic Kidney ... Hyperparathyroi... Vitamin D Defic... | CTAP101 Capsule... Calcitriol Doxercalciferol Paricalcitol | 18 Years - | OPKO Health, Inc. | |
| Combination Therapy for Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma | NCT02754726 | Untreated Metas... | Nivolumab Albumin-bound p... Paricalcitol Cisplatin Gemcitabine | 18 Years - | HonorHealth Research Institute | |
| Paricalcitol in Treating Patients With Myelodysplastic Syndrome | NCT00064376 | Leukemia Myelodysplastic... | paricalcitol | 25 Years - 100 Years | Cedars-Sinai Medical Center | |
| Paricalcitol and Zoledronate in Treating Patients With Relapsed or Refractory Multiple Myeloma or Other Plasma Cell Disorders | NCT00258258 | Multiple Myelom... | paricalcitol zoledronic acid | 18 Years - | Roswell Park Cancer Institute | |
| Vitamin D Deficiency in Chronic Kidney Disease (CKD) Patients | NCT00958451 | Secondary Hyper... Chronic Kidney ... | Paricalcitol Ergocalciferol | 18 Years - | Salem Veterans Affairs Medical Center | |
| Extension Study of CTAP101-CL-3001 or CTAP101-CL-3002 | NCT02282813 | Chronic Kidney ... Hyperparathyroi... Vitamin D Defic... | CTAP101 Capsule... Calcitriol Doxercalciferol Paricalcitol | 18 Years - | OPKO Health, Inc. | |
| Treatment of Secondary Hyperparathyroidism in the Uremic Patient | NCT00469599 | Secondary Hyper... Chronic Kidney ... Vitamin D Defic... | paricalcitol alfacalcidol | 18 Years - | Zealand University Hospital | |
| A Study to Assess the Efficacy and Safety of Paricalcitol in the Treatment of Chronic Kidney Disease With Secondary Hyperparathyroidism | NCT04994080 | Secondary Hyper... | Paricalcitol Placebo | 18 Years - | Chengdu Suncadia Medicine Co., Ltd. | |
| Paricalcitol Trial: Phase II, Open Label Clinical Trial of Paricalcitol in Combination With Gemcitabine/ Nab-Paclitaxel Therapy in Advanced Pancreatic Cancer | NCT04617067 | Advanced Pancre... | Paricalcitol Gemcitabine (GE... | 18 Years - | Cancer Trials Ireland | |
| Paricalcitol and Gemcitabine in Treating Patients With Advanced Cancer | NCT00217477 | Unspecified Adu... | gemcitabine hyd... paricalcitol | 18 Years - | Roswell Park Cancer Institute | |
| A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism | NCT01149291 | Secondary Hyper... End Stage Renal... | 18 Years - | AbbVie | ||
| Paricalcitol and Zoledronate in Treating Patients With Relapsed or Refractory Multiple Myeloma or Other Plasma Cell Disorders | NCT00258258 | Multiple Myelom... | paricalcitol zoledronic acid | 18 Years - | Roswell Park Cancer Institute | |
| Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kidney Disease (CKD) With Secondary Hyperparathyroidism (SHPT) | NCT00823303 | Secondary Hyper... Chronic Kidney ... | Paricalcitol Calcitriol | 18 Years - | Washington University School of Medicine | |
| Initial Dosing of Paricalcitol in Secondary Hyperparathyroidism | NCT00307840 | Secondary Hyper... | paricalcitol | 18 Years - | Papageorgiou General Hospital | |
| Paricalcitol Addition to Chemotherapy in Patients With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma | NCT04054362 | Pancreatic Canc... | Paclitaxel prot... Cisplatin Gemcitabine Paricalcitol | 18 Years - | Barts & The London NHS Trust | |
| Treatment of Secondary Hyperparathyroidism in the Uremic Patient | NCT00469599 | Secondary Hyper... Chronic Kidney ... Vitamin D Defic... | paricalcitol alfacalcidol | 18 Years - | Zealand University Hospital | |
| Paricalcitol Trial: Phase II, Open Label Clinical Trial of Paricalcitol in Combination With Gemcitabine/ Nab-Paclitaxel Therapy in Advanced Pancreatic Cancer | NCT04617067 | Advanced Pancre... | Paricalcitol Gemcitabine (GE... | 18 Years - | Cancer Trials Ireland | |
| Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D | NCT00977080 | Chronic Kidney ... Secondary Hyper... Hemodialysis | Paricalcitol Cinacalcet | 18 Years - | Abbott | |
| Paricalcitol Compared to Maxacalcitol in Chronic Kidney Disease Patients With Secondary Hyperparathyroidism | NCT00990704 | Secondary Hyper... Hemodialysis | paricalcitol maxacalcitol | 20 Years - | Abbott | |
| A Pilot Study of Perioperative Nivolumab and Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer | NCT03519308 | Pancreatic Canc... | Nivolumab Nab-Paclitaxel Gemcitabine Paricalcitol | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyroidism in Calcitriol Resistant Dialysis Subjects | NCT00664430 | Secondary Hyper... Dialysis | Calcitriol Paricalcitol | 18 Years - | Abbott | |
| Paricalcitol and Hydroxychloroquine in Combination With Gemcitabine and Nab-Paclitaxel for Advanced Pancreatic Cancer | NCT04524702 | Advanced Pancre... Metastatic Panc... Stage IV Pancre... | Gemcitabine Hydroxychloroqu... Nab-paclitaxel Paricalcitol | 18 Years - | Emory University | |
| Initial Dosing of Paricalcitol in Secondary Hyperparathyroidism | NCT00307840 | Secondary Hyper... | paricalcitol | 18 Years - | Papageorgiou General Hospital | |
| Paricalcitol Compared to Maxacalcitol in Chronic Kidney Disease Patients With Secondary Hyperparathyroidism | NCT00990704 | Secondary Hyper... Hemodialysis | paricalcitol maxacalcitol | 20 Years - | Abbott | |
| A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer | NCT03331562 | Pancreatic Canc... Pancreas Adenoc... Advanced Pancre... Metastatic Panc... Metastatic Panc... | Pembrolizumab paricalcitol placebo | 18 Years - | Translational Genomics Research Institute | |
| A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer | NCT03331562 | Pancreatic Canc... Pancreas Adenoc... Advanced Pancre... Metastatic Panc... Metastatic Panc... | Pembrolizumab paricalcitol placebo | 18 Years - | Translational Genomics Research Institute | |
| Paricalcitol and Chemotherapy in Treating Women With Metastatic Breast Cancer | NCT00637897 | Breast Cancer | docetaxel ixabepilone paclitaxel paclitaxel albu... paricalcitol | 18 Years - 120 Years | Wake Forest University Health Sciences | |
| Paricalcitol in Reducing Parathyroid Hormone Levels and Ameliorating Markers of Bone Remodelling in Renal Transplant Recipients With Secondary Hyperparathyroidism | NCT01220050 | Renal Transplan... Secondary Hyper... | Paricalcitol Standard therap... | 18 Years - 80 Years | Mario Negri Institute for Pharmacological Research | |
| Paricalcitol in Reducing Parathyroid Hormone Levels and Ameliorating Markers of Bone Remodelling in Renal Transplant Recipients With Secondary Hyperparathyroidism | NCT01220050 | Renal Transplan... Secondary Hyper... | Paricalcitol Standard therap... | 18 Years - 80 Years | Mario Negri Institute for Pharmacological Research | |
| Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patients Receiving Hemodialysis | NCT00667576 | Chronic Kidney ... Secondary Hyper... | Maxacalcitol Paricalcitol | 20 Years - | Abbott | |
| A Randomized Pilot/Pharmacodynamic/Genomic Study of Neoadjuvant Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer | NCT02030860 | Adenocarcinoma ... | Paricalcitol Abraxane Gemcitabine | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyroidism in Calcitriol Resistant Dialysis Subjects | NCT00664430 | Secondary Hyper... Dialysis | Calcitriol Paricalcitol | 18 Years - | Abbott | |
| Paricalcitol in Treating Patients With Advanced Prostate Cancer and Bone Metastases | NCT00634582 | Metastatic Canc... Prostate Cancer | paricalcitol immunoenzyme te... laboratory biom... dual x-ray abso... quality-of-life... | 18 Years - 120 Years | Wake Forest University Health Sciences | |
| A Pilot Study of Perioperative Nivolumab and Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer | NCT03519308 | Pancreatic Canc... | Nivolumab Nab-Paclitaxel Gemcitabine Paricalcitol | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| Long-term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Patients With Hemodialysis (HD) | NCT00701805 | Secondary Hyper... Hemodialysis | Paricalcitol | 20 Years - | Abbott | |
| A Phase Ib Pharmacodynamic Study of Neoadjuvant Paricalcitol in Resectable Pancreatic Cancer A Phase Ib Pharmacodynamic Study of Neoadjuvant Paricalcitol in Resectable Pancreatic Cancer | NCT03300921 | Pancreatic Canc... | Paricalcitol | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| Efficacy and Safety of Paricalcitol in the Reduction of Secondary Hyperparathyroidism After Kidney Transplantation. | NCT01939977 | Secondary Hyper... | Paricalcitol Calcifediol | 18 Years - | Fundación Senefro | |
| Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kidney Disease (CKD) With Secondary Hyperparathyroidism (SHPT) | NCT00823303 | Secondary Hyper... Chronic Kidney ... | Paricalcitol Calcitriol | 18 Years - | Washington University School of Medicine | |
| Paricalcitol Compared to Maxacalcitol in Chronic Kidney Disease Patients With Secondary Hyperparathyroidism | NCT00990704 | Secondary Hyper... Hemodialysis | paricalcitol maxacalcitol | 20 Years - | Abbott | |
| Long-term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Patients With Hemodialysis (HD) | NCT00701805 | Secondary Hyper... Hemodialysis | Paricalcitol | 20 Years - | Abbott |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
